Amgen Chooses Veeva Vault CRM to Enhance Global Biotech Operations

Amgen, a leading biotechnology company, has made a significant decision to implement Veeva Vault CRM on a global scale. This move signifies not just a technological upgrade, but also an enhancement of a collaboration that has been developing over the past decade. The goal is clear: to accelerate the delivery of innovative therapeutic solutions to patients around the world.

Streamlining the Path to Innovation

According to Scott Skellenger, Amgen's Senior Vice President and Chief Information Officer, the transition to Vault CRM will facilitate faster and more agile responses in bringing new therapies to market. With Veeva’s extensive knowledge of the life sciences sector and a steadfast commitment to innovation, Amgen aims to achieve important milestones that address the needs of patients facing some of the world’s toughest health challenges.

What is Vault CRM?

Vault CRM is part of the comprehensive Vault CRM Suite, designed to revolutionize how companies engage with healthcare professionals (HCPs). This platform equips sales agents with the necessary tools to foster meaningful connections while improving the efficiency of commercial operations. The introduction of the Agentic Call Report feature allows for the collection of commercial evidence and identification of previously overlooked treatment barriers, ultimately leading to enhanced patient outcomes.

A Partnership for Progress

Matt Farrell, President of Commercial Strategy at Veeva, indicated that this collaboration with Amgen will support the launch of vital new treatments on a global scale. He emphasized that Vault CRM serves as a robust foundation for Amgen’s commercial activities, promising a transformative effect on their approach to market rollout. The strategic partnership inherits a philosophy that places patient needs at the forefront, aiming to create more effective pathways for therapy access.

Veeva Systems: A Leader in Life Sciences Cloud Solutions

Veeva Systems offers an industry-specific cloud environment tailored for life sciences, which includes applications that enhance operational efficiency and productivity. With a customer base exceeding 1,500, Veeva caters to a wide range of clients, from the largest pharmaceutical corporations to emerging biotech firms. Their public benefit corporation status underscores a commitment to balancing stakeholder interests, including those of customers, employees, and the communities they serve.

In its latest announcement, Veeva expressed its eagerness to assist Amgen in meeting its ambitious goals through the deployment of this innovative CRM system. By aligning technological advancements with healthcare needs, both companies hope to pave the way for innovative treatments that can effectively tackle complex diseases.

Navigating Forward: The Future of Healthcare

This strategic alliance between Amgen and Veeva illustrates a growing trend within the biotechnology industry towards integrating advanced technology solutions that enhance operational effectiveness. As patient needs become increasingly complex, the ability to adapt and innovate in real-time is crucial.

The migration to Veeva Vault CRM will not only optimize Amgen's engagement processes but also ensure that the company remains at the forefront of delivering essential therapies in a rapidly evolving healthcare landscape. With the commitment from both teams, the future looks promising for innovative biotech solutions aimed at improving patient care and health outcomes worldwide.

As companies in the biotechnology sector continue to explore digital solutions, collaborations like this one between Amgen and Veeva offer insights into how technology can drive healthcare transformation, setting the stage for a healthier future.